PROBLEM TO BE SOLVED: To provide a composition, method, and product for treatment of ocular disorders (for instance, a disorder characterized by macular degeneration, choroidal neovascularization, or retinal angiogenesis).SOLUTION: Provided is a method for administering the 1st and 2nd therapeutic agents to the eyes of a subject by a single procedure. The 1st therapeutic agent is used for rapidly improving a symptom of the eyes of the subject, and the 2nd therapeutic agent is dosed as a releasing preparation for the 2nd therapeutic agent. For instance, the 1st and 2nd therapeutic agents can be dosed by an intravitreal infusion, wherein the 1st therapeutic agent is allowed to dissolve in a liquid medium in a syringe, and the 2nd therapeutic agent as the releasing preparation is allowed to contain an intraocular implant or two or more particles existing in an injection needle. The therapeutic agents are allowed to be selected from a group consisting of neovascularization inhibitors and complement inhibitors.【課題】眼の障害（例えば黄斑退化、脈絡膜血管新生又は網膜血管新生によって特徴付けられる障害）の治療のための組成物、方法及び製品の提供。【解決手段】単一の手順で被験者の眼に第一及び第二の治療薬を投与するステップであり、第一の治療薬は被験者の眼の症状を急速に改善させるものであり、第二の治療薬は第二の治療薬用の放出性調剤として投与される方法。例えば、第一及び第二の治療薬は硝子体内注入法により投与され、第一の治療薬は注射器内の液体媒質に溶解しても良いし、第二の治療薬の放出性調剤は注射針の中にある眼内インプラント又は複数の粒子を含んでも良い。治療薬は血管新生阻害剤及び補体阻害剤からなる群から選択しても良い。【選択図】なし
